Refractory celiac disease is an uncommon condition which might be associated to poor prognosis. It is often treated with immunosuppressive medications, with poor results. It is divided in type 1 and type 2, the latter carrying a high risk for lymphoma and mortality. A case of a 41 year old female patient with refractory celiac disease type 2 is reported. She was treated with oral budesonide for six months, achieving histological remission.
CITATION STYLE
Soldera, J., Salgado, K., & Pêgas, K. L. (2021). Refractory celiac disease type 2: How to diagnose and treat? Revista Da Associacao Medica Brasileira, 67(2), 168–172. https://doi.org/10.1590/1806-9282.67.02.20200618
Mendeley helps you to discover research relevant for your work.